PDL BioPharma, Inc. Free Cash Flow Margin

Free Cash Flow Margin of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Free Cash Flow Margin growth rates and interactive chart. Free cash flow margin or Free cash flow-to-sales is a performance ratio that measures operating cash flows after deduction of capital expenditures (free cash flow) relative to sales. Free cash flows (FCF) is an important metric in assessing a company's financial condition and determining its intrinsic valuation. FCF/sales is tracked over time and can be compared to a company's historical record or to peers. Free cash flow is useful because it takes out non-cash items out of earnings and only looks at the underlying operating cash coming in and out of a business minus the necessary capital expenditures.

Highlights and Quick Summary

  • Annual Free Cash Flow Margin for 2019 was 90.15% (a 346.29% increase from previous year)
  • Annual Free Cash Flow Margin for 2018 was 20.2% (a -55.9% decrease from previous year)
  • Annual Free Cash Flow Margin for 2017 was 45.8% (a -2.51% decrease from previous year)
  • Twelve month Free Cash Flow Margin ending June 29, 2020 was -13.21% (a -84.55% decrease compared to previous quarter)
  • Twelve month trailing Free Cash Flow Margin decreased by -120.76% year-over-year
Trailing Free Cash Flow Margin for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
-13.21% -85.48% 128.36% 63.63%
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Free Cash Flow Margin of PDL BioPharma, Inc.

Most recent Free Cash Flow Marginof PDLI including historical data for past 10 years.

Interactive Chart of Free Cash Flow Margin of PDL BioPharma, Inc.

PDL BioPharma, Inc. Free Cash Flow Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2019 90.15%
2018 20.2%
2017 45.8%
2016 46.98%
2015 38.93%
2014 53.95%
2013 6.23%
2012 55.78%
2011 46.9%
2010 53.42%

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.